Common Contracts
8 similar Control and Severance Agreement contracts by Cortexyme, Inc., Getaround, Inc
FORM OF EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENT FOR TIER 2 EXECSControl and Severance Agreement • November 16th, 2023 • Getaround, Inc • Services-auto rental & leasing (no drivers) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between ____________________ (“Executive”) and Getaround, Inc. (the “Company”), effective as of _______________ (the “Effective Date”). Unless otherwise renewed in the Company’s discretion, this Agreement shall terminate on the three (3) year anniversary of the Effective Date.
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • October 29th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Ted Monohon (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of September 21, 2021 (the “Effective Date”).
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • August 6th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Stephen S. Dominy, M.D. (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of May 19, 2020 (the “Effective Date”).
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • August 6th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Casey C. Lynch (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of May 19, 2020 (the “Effective Date”).
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • August 6th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Leslie Holsinger, Ph.D. (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of May 18, 2020 (the “Effective Date”).
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • August 6th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Caryn McDowell (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of May 18, 2020 (the “Effective Date”).
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • August 6th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christopher Lowe (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of May 18, 2020 (the “Effective Date”).
CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • August 6th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
This Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Michael Detke (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of May 21, 2020 (the “Effective Date”).
